Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01140074
Other study ID # KB-501/2009
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received June 7, 2010
Last updated June 9, 2010
Start date July 2010
Est. completion date June 2012

Study information

Verified date June 2010
Source University Hospital No 1 Wroclaw
Contact Leszek Szenborn, Prof
Phone ++48717703151
Email szenborn@zak.am.wroc.pl
Is FDA regulated No
Health authority Poland: Ethics Committee
Study type Interventional

Clinical Trial Summary

Diarrheal disease is one of the major causes of morbidity and mortality in children under five. Disease is treated symptomatically with oral rehydration (ORS) as a basic measure. In children with severe zinc deficiency, diarrhea is common and responds quickly to zinc supplementation. Zinc supplementation may also helpful in diarrheal children without zinc deficiency. Effectiveness of zinc was proven in developing countries but was not in Europe. Objective of our study is to assess whether zinc supplementation given with probiotics and ORS is effective in acute diarrhea in children in Poland.


Description:

A double-blind, placebo controlled trial

- We are going to enroll 256 patients (aged > 1 months to 36 months) with acute watery diarrhea defined as 3 d or more watery stools per day lasting not less than 1 day and not longer than 5 days.

Exclusion criteria:

severe dehydration (> 10%) Coexisting severe infection (E.g. Sepsis, pneumonia, meningitis) Immune deficiency Chronic digestive tract disease (e.g. celiac diseases, food allergy) Therapy with Antibiotics

Patients will be randomly assigned to 2 groups to receive: (a) zinc sulfate 10-20 mg/day for 10 days plus probiotics for 5 days (b) placebo for 10 days plus probiotics for 5 days. Patients will be observed in ambulatory or in the hospital (if necessary) and followed up for 15 days.

Randomization 1:1


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 256
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 1 Month to 36 Months
Eligibility Inclusion Criteria:

- Age 1-36 months

- Acute diarrhea defined as 3 or more watery stools per day

- Informed consent (parents)

Exclusion Criteria:

- Severe dehydration (> 10%)

- Coexisting severe infection (e.g. sepsis, pneumonia, meningitis)

- Immune deficiency

- Chronic digestive tract disease (e.g. celiac diseases, food allergy)

- Antibiotic therapy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Zinc Sulfate
Zinc Sulfate in sugar sirup will be given orally in dosis of 10-20 mg per day for 10 days

Locations

Country Name City State
Poland Szpital im Sw Jadwigi w Trzebicy Trzebnica
Poland Klinika Pediatrii i Chorob Infekcyjnych Akademii Medycznej we Wroclawiu Wroclaw

Sponsors (1)

Lead Sponsor Collaborator
University Hospital No 1 Wroclaw

Country where clinical trial is conducted

Poland, 

References & Publications (4)

Boran P, Tokuc G, Vagas E, Oktem S, Gokduman MK. Impact of zinc supplementation in children with acute diarrhoea in Turkey. Arch Dis Child. 2006 Apr;91(4):296-9. Epub 2005 Dec 14. — View Citation

Fajolu IB, Emokpae A, Oduwole AO, Silva BO, Abidoye RO, Renner JK. Zinc supplementation in children with acute diarrhoea. Nig Q J Hosp Med. 2008 Apr-Jun;18(2):101-3. — View Citation

Larson CP, Nasrin D, Saha A, Chowdhury MI, Qadri F. The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double-blind field trial. Trop Med Int Health. 2010 Jun;15(6):754-61. doi: 10.1111/j.1365-3156.2010.02525.x. Epub 2010 Mar 29. — View Citation

Roy SK, Tomkins AM, Akramuzzaman SM, Behrens RH, Haider R, Mahalanabis D, Fuchs G. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child. 1997 Sep;77(3):196-200. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Period of diarrhea in hours The primary endpoint of our study is the time of acute diarrhea 15 days No
Secondary number of stools in consequent days The secondary end points will be number of stools per day, necessity of hospitalization or not, tolerability and adherence to the therapy 15 days Yes
See also
  Status Clinical Trial Phase
Completed NCT00325247 - Efficacy of Zinc Therapy in Acute Diarrhoea in Young Children Phase 3
Completed NCT06179589 - VS002A in the Treatment of Acute Watery Diarrhea in Infants and Young Children N/A